TRIM33 and cancer: The association of anti‐TIF‐1γ antibody and increased risk of cancer in adult DM has recently been highlighted (4, 5) and characteristic cutaneous findings, such as palmar hyperkeratotic papules, psoriasis‐like lesions, and hypopigmented and telangiectatic "red‐on‐white" patches have been described (6).